Primary mediastinal large B-cell lymphoma: Optimal therapy and prognostic factor analysis in 141 consecutive patients treated at memorial Sloan Kettering from 1980 to 1999

British Journal of Haematology

Volumn 130, Issue 5, 2005, Pages 691-699

  Hamlin, Paul A ^a   Portlock, Carol S ^a   Straus, David J ^a   Noy, Ariela ^a   Singer, Andrew ^a   Horwitz, Steven M ^a   Oconnor, Owen A ^a   Yahalom, Joachim ^a   Zelenetz, Andrew D ^a   Moskowitz, Craig H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemotherapy; Cyclophosphamide; Hydroxydaunomycin; Non Hodgkin lymphoma; Oncovin; Prednisone; Risk factors; Transplant

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DAUNORUBICIN DERIVATIVE; DOXORUBICIN; ETOPOSIDE; GALLIUM; HYDROXYDAUNORUBICIN; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISONE; UNCLASSIFIED DRUG; VINCRISTINE SULFATE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COURSE EVALUATION; DIAGNOSTIC IMAGING; DISEASE FREE SURVIVAL; DRUG DOSE REGIMEN; FOLLOW UP; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MEDIASTINUM CANCER; MEDICAL ASSESSMENT; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; AUTOTRANSPLANTATION; FACTORIAL ANALYSIS; FEMALE; HISTIOCYTIC LYMPHOMA; MALE; MEDIASTINUM TUMOR; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; STEM CELL TRANSPLANTATION; SURVIVAL;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 27244432753     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05661.x     Document Type: Article

References (42)

1. Abou-Elella A.A. Weisenburger D.D. Vose J.M. Kollath J.P. Lynch J.C. Bast M.A. Bierman P.J. Greiner T.C. Chan W.C. Armitage J.O. ( 1999) Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. Journal of Clinical Oncology, 17, 784 790.
2. Armitage J.O. Weisenburger D.D. ( 1998) New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's lymphoma classification project. Journal of Clinical Oncology, 16, 2780 2795.
3. Bertini M. Orsucci L. Vitolo U. Levis A. Todeschini G. Meneghini V. Novero D. Tarella C. Gallo E. Luxi G. Pizzuti M. Novarino A. Urgesi A. Resegotti L. ( 1991) Stage II large B-cell lymphoma with sclerosis treated with MACOP-B. Annals of Oncology, 2, 733 737.
4. van Besien K. Kelta M. Bahaguna P. ( 2001) Primary mediastinal B-cell lymphoma: a review of pathology and management. Journal of Clinical Oncology, 19, 1855 1864.
5. Bieri S. Roggero E. Zucca E. Bertoni F. Pianca S. Sanna P. Pedrinis E. Bernier J. Cavalli F. ( 1999) Primary mediastinal large B-cell lymphoma (PMLCL): the need for prospective controlled clinical trials. Leukemia and Lymphoma, 35, 139 146.
6. Blayney D.W. LeBlanc M.L. Grogan T. Gaynor E.R. Chapman R.A. Spiridonidis C.H. Taylor S.A. Bearman S.I. Miller T.P. Fisher R.I. ( 2003) Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349). Journal of Clinical Oncology, 21, 2466 2473.
7. Cazals-Hatem D. Lepage E. Brice P. Ferrant A. d'Agay M.F. Baumelou E. Briere J. Blanc M. Gaulard P. Biron P. Schlaifer D. Diebold J. Audouin J. ( 1996) Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (''Groupe d'Etude des Lymphomes de l'Adulte'') study. American Journal of Surgical Pathology, 20, 877 888.
8. Cazals-Hatem D. Andre M. Mounier N. Copin M.C. Divine M. Berger F. Bosly A. Kerneis Y. Briere J. Quesnel B. Diebold J. Gaulard P. ( 2001) Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study. American Journal of Surgical Pathology, 25, 297 306.
9. Citron M.L. Berry D.A. Cirrincione C. Hudis C. Winer E.P. Gradishar W.J. Davidson N.E. Martino S. Livingston R. Ingle J.N. Perez E.A. Carpenter J. Hurd D. Holland J.F. Smith B.L. Sartor C.I. Leung E.H. Abrams J. Schilsky R.L. Muss H.B. Norton L. ( 2003) Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. Journal of Clinical Oncology, 21, 1431 1439.
10. Cox D. ( 1972) Regression models and life-tables. Journal of the Royal Statistical Society [B], 34, 187 220.
11. Deshpande A. Bierman P.J. Vose J. Bast M.A. Bociek J. Lynch J.C. Armitage J.O. ( 2004) Diffuse large B cell lymphoma with mediastinal mass at presentation. Journal of Clinical Oncology, 22 ( Suppl. S abstract 6585, 578.
12. Fisher R.I. Gaynor E.R. Dahlberg S. Oken M.M. Grogan T.M. Mize E.M. Glick J.H. Coltman Jr., C.A. Miller T.P. ( 1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. New England Journal of Medicine, 328, 1002 1006.
13. Gulati S.C. Shank B. Black P. Yopp J. Koziner B. Straus D. Filippa D. Kempin S. Castro-Malaspina H. Cunningham I. Berman E. Coleman M. Langleben A.O. Colvin M Fuks Z. O'Reilly R. Clarkson B. ( 1988) Autologous bone marrow transplantation for patients with poor-prognosis lymphoma. Journal of Clinical Oncology, 6, 1303 1313.
14. Haioun C. Gaulard P. Roudot-Thoraval F. Divine M. Jouault H. Lebourgeois J.P. Kuentz M. Farcet J.P. Reyes F. ( 1989) Mediastinal diffuse large-cell lymphoma with sclerosis: a condition with a poor prognosis. American Journal of Clinical Oncology, 12, 425 429.
15. Harris N.L. Jaffe E.S. Stein H. Banks P.M. Chan J.K. Cleary M.L. Delsol G. De Wolf-Peeters C. Falini B. Gatter K.C. ( 1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361 1392.
16. Harris N.L. Jaffe E.S. Diebold J. Flandrin G. Muller-Hermelink H.K. Vardiman J. Lister T.A. Bloomfield C.D. ( 1999a) The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Annals of Oncology, 10, 1419 1432.
17. Harris N.L. Jaffe E.S. Diebold J. Flandrin G. Muller-Hermelink H.K. Vardiman J. Lister T.A. Bloomfield C.D. ( 1999b) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. Journal of Clinical Oncology, 17, 3835 3849.
18. Isaacson P.G. Norton A.J. Addis B.J. ( 1987) The human thymus contains a novel population of B lymphocytes. Lancet, 2, 1488 1491.
19. Itoh K. Ohtsu T. Fukuda H. Sasaki Y. Ogura M. Morishima Y. Chou T. Aikawa K. Uike N. Mizorogi F. Ohno T. Ikeda S. Sai T. Taniwaki M. Kawano F. Niimi M. Hotta T. Shimoyama M. Tobinai K. ( 2002) Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505. Annals of Oncology, 13, 1347 1355.
20. Kaplan E. Meier P. ( 1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457 481.
21. Kirn D. Mauch P. Shaffer K. Pinkus G. Shipp M.A. Kaplan W.D. Tung N. Wheeler C. Beard C.J. Canellos G.P. Shulman L.N. ( 1993) Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. Journal of Clinical Oncology, 11, 1336 1343.
22. Lamarre L. Jacobson J.O. Aisenberg A.C. Harris N.L. ( 1989) Primary large cell lymphoma of the mediastinum. A histologic and immunophenotypic study of 29 cases. American Journal of Surgical Pathology, 13, 730 739.
23. Lazzarino M. Orlandi E. Paulli M. Boveri E. Morra E. Brusamolino E. Kindl S. Rosso R. Astori C. Buonanno M.C. Magrini U. Bernasconi C. ( 1993) Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features. Journal of Clinical Oncology, 11, 2306 2313.
24. Lazzarino M. Orlandi E. Paulli M. Strater J. Klersy C. Gianelli U. Gargantini L. Rousset M.T. Gambacorta M. Marra E. Lavabre-Bertrand T. Magrini U. Manegold C. Bernasconi C. Moller P. ( 1997) Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. Journal of Clinical Oncology, 15, 1646 1653.
25. Levitt L.J. Aisenberg A.C. Harris N.L. Linggood R.M. Poppema S. ( 1982) Primary non-Hodgkin's lymphoma of the mediastinum. Cancer, 50, 2486 2492.
26. Lichtenstein A.K. Levine A. Taylor C.R. Boswell W. Rossman S. Feinstein D.I. Lukes R.J. ( 1980) Primary mediastinal lymphoma in adults. American Journal of Medicine, 68, 509 514.
27. Mantel N. ( 1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports, 50, 163 170.
28. Nguyen L.N. Ha C.S. Hess M. Romaguera J.E. Manning J.T. Cabanillas F. Cox J.D. ( 2000) The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum. International Journal of Radiation Oncology, Biology, Physics, 47, 1281 1285.
29. Norton L. Simon R. Brereton H.D. Bogden A.E. ( 1976) Predicting the course of Gompertzian growth. Nature, 264, 542 545.
30. Palanisamy N. Abou-Elella A.A. Chaganti S.R. Houldsworth J. Offit K. Louie D.C. Terayu-Feldstein J. Cigudosa J.C. Rao P.H. Sanger W.G. Weisenburger D.D. Chaganti R.S. ( 2002) Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma. Genes Chromosomes Cancer, 33, 114 122.
31. Pfreundschuh M. Trumper L. Kloess M. Schmits R. Feller A.C. Rube C. Rudolph C. Reiser M. Hossfeld D.K. Eimermacher H. Hasenclever D. Schmitz N. Loeffler M. ( 2004a) Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Blood, 104, 634 641.
32. Pfreundschuh M. Trumper L. Kloess M. Schmits R. Feller A.C. Rudolph C. Reiser M. Hossfeld D.K. Metzner B. Hasenclever D. Schmitz N. Glass B. Rube C. Loeffler M. ( 2004b) Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL. Blood, 104, 626 633.
33. Portlock C.S. Qin J. Schaindlin P. Roistacher N. Myers J. Filippa D. Louie D. Zelenetz A.D. O'Brien J.P. Moskowitz C. Norton L. Yahalom J. Straus D.J. Bertino J.R. ( 2004) The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide. Annals of Oncology, 15, 1495 1503.
34. Rodriguez J. Pugh W.C. Romaguera J.E. Cabanillas F. ( 1994) Primary mediastinal large cell lymphoma. Hematology Oncology, 12, 175 184.
35. Rosenwald A. Wright G. Leroy K. Yu X. Gaulard P. Gascoyne R.D. Chan W.C. Zhao T. Haioun C. Greiner T.C. Weisenburger D.D. Lynch J.C. Vose J. Armitage J.O. Smeland E.B. Kvaloy S. Holte H. Delabie J. Campo E. Montserrat E. Lopez-Guillermo A. Ott G. Muller-Hermelink H.K. Connors J.M. Braziel R. Grogan T.M. Fisher R.I. Miller T.P. LeBlanc M. Chiorazzi M. Zhao H. Yang L. Powell J. Wilson W.H. Jaffe E.S. Simon R. Klausner R.D. Staudt L.M. ( 2003) Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. Session type: oral session. Blood, 102, Abstract no. 208, 62a.
36. Savage K.J. Monti S. Kutok J.L. Cattoretti G. Neuberg D. De Leval L. Kurtin P. Dal Cin P. Ladd C. Feuerhake F. Aguiar R.C. Li S. Salles G. Berger F. Jing W. Pinkus G.S. Habermann T. Dalla-Favera R. Harris N.L. Aster J.C. Golub T.R. Shipp M.A. ( 2003) The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood, 102, 3871 3879.
37. Shipp M. Harrington D. Anderson J.R. Armitage J.O. Bonadonna G. Brittinger G. Cabanillas F. Canellos G.P. Coiffier B. Connors J.M. Cowan R.A. Crowther D. Dahlberg S. Engelhard M. Fisher R.I. Gisselbrecht C. Horning S.J. Lepage E. Lister T.A. Meerwaldt J.H. Montserrat E. Nissen N.I. Oken M.M. Peterson B.A. Tondini C. Velasquez W.A. Yeap B.Y. ( 1993) A predictive model for aggressive non-Hodgkin's lymphoma. The International non-Hodgkin Lymphoma Prognostic Factors Project. New England Journal of Medicine, 329, 987 994.
38. Todeschini G. Ambrosetti A. Meneghini V. Pizzolo G. Menestrina F. Chilosi M. Benedetti F. Veneri D. Cetto G.L. Perona G. ( 1990) Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients. Journal of Clinical Oncology, 8, 804 808.
39. Todeschini G. Secchi S. Morra E. Vitolo U. Orlandi E. Pasini F. Gallo E. Ambrosetti A. Tecchio C. Tarella C. Gabbas A. Gallamini A. Gargantini L. Pizzuti M. Fioritoni G. Gottin L. Rossi G. Lazzarino M. Menestrina F. Paulli M. Palestro M. Cabras M.G. Di Vito F. Pizzolo G. ( 2004) Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. British Journal of Cancer, 90, 372 376.
40. Zinzani P.L. Martelli M. Magagnoli M. Pescarmona E. Scaramucci L. Palombi F. Bendandi M. Martelli M.P. Ascani S. Orcioni G.F. Pileri S.A. Mandelli F. Tura S. ( 1999) Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients. Blood, 94, 3289 3293.
41. Zinzani P.L. Martelli M. Bendandi M. De Renzo A. Zaccaria A. Pavone E. Bocchia M. Falini B. Gobbi M. Gherlinzoni F. Stefoni V. Tani M. Tura S. ( 2001) Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy. Haematologica, 86, 187 191.
42. Zinzani P.L. Martelli M. Bertini M. Gianni A.M. Devizzi L. Federico M. Pangalis G. Michels J. Zucca E. Cantonetti M. Cortelazzo S. Wotherspoon A. Ferreri A.J. Zaja F. Lauria F. De Renzo A. Liberati M.A. Falini B. Balzarotti M. Calderoni A. Zaccaria A. Gentilini P. Fattori P.P. Pavone E. Angelopoulou M.K. Alinari L. Brugiatelli M. Di Renzo N. Bonifazi F. Pileri S.A. Cavalli F. ( 2002) Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Haematologica, 87, 1258 1264.